← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2003Last known activity
May 1, 2013
Timeline
2000s
- Jan 1, 2003
Innogene Kalbiotech Pte. Ltd— Founded
Drugs by trial phase (7 distinct, 10 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiac Output, Low
- Coronary Artery Disease
- Coronary Disease
- Dengue
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Myocardial Ischemia
- Neoplasms, Squamous Cell
- Severe Dengue
- Shock
- Shock, Hemorrhagic
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
Recent trials (10)
- NCT02268045CollaboratorPhase 3May 1, 2013
- NCT01460472CollaboratorPhase 3Sep 1, 2010
- NCT01981655CollaboratorPhase 2Dec 1, 2009
- NCT00957086CollaboratorPhase 3Aug 1, 2009
- NCT01433276Lead sponsorPhase 3Jul 1, 2009
- NCT01654653Lead sponsorPhase 4Jul 1, 2008
- NCT00966628Lead sponsorPhase 3May 1, 2008
- NCT00702481CollaboratorPhase 2Apr 1, 2008
- NCT00529711Lead sponsorPhase 3Jul 1, 2005
- NCT00529490Lead sponsorPhase 3Mar 1, 2002
Details
- Founded
- Bukit Batok, SG Jan 1, 2003
- Last known activity
- May 1, 2013